Voya Investment Management LLC Chimerix Inc Transaction History

Voya Investment Management LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$1.34 - $5.34 $7,087 - $28,243	5,289 Added 18.05%	34,598 $72,000
Q4 2021 Feb 14, 2022	BUY	$5.23 - $7.18 $1,464 - $2,010	280 Added 0.96%	29,309 $188,000
Q2 2021 Aug 16, 2021	BUY	$7.54 - $9.79 $25,613 - $33,256	3,397 Added 13.25%	29,029 $232,000
Q1 2021 May 17, 2021	BUY	$4.76 - $11.25 $9,648 - $22,803	2,027 Added 8.59%	25,632 $247,000
Q4 2020 Feb 16, 2021	SELL	$2.43 - $5.42 $55,591 - $123,993	-22,877 Reduced 49.22%	23,605 $114,000
Q3 2020 Nov 16, 2020	BUY	$2.3 - $3.72 $68,342 - $110,536	29,714 Added 177.21%	46,482 $116,000
Q2 2020 Aug 14, 2020	SELL	$1.33 - $3.63 $18,584 - $50,721	-13,973 Reduced 45.45%	16,768 $52,000
Q4 2019 Feb 14, 2020	BUY	$1.3 - $2.72 $10,896 - $22,799	8,382 Added 37.49%	30,741 $62,000
Q2 2018 Aug 14, 2018	SELL	$4.43 - $5.14 $17,272 - $20,040	-3,899 Reduced 14.85%	22,359 $106,000
Q1 2018 May 15, 2018	SELL	$4.65 - $5.9 $13,694 - $17,375	-2,945 Reduced 10.08%	26,258 $137,000
Q3 2017 Nov 14, 2017	BUY	$4.35 - $5.25 $127,033 - $153,315	29,203	29,203 $153,000

36.8M

72.2K

169K

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $85M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Voya Investment Management LLC with notifications on news.